Efficacy of combining targeted therapy with pemetrexed or docetaxel as second-line treatment in patients with advanced non-small-cell lung cancer: a meta-analysis of 14 randomized controlled trials

Li Xuyuan; Wang Hongbiao; Lin Wenzhao; Xu Qini

首页> 外文期刊>Current medical research and opinion >Efficacy of combining targeted therapy with pemetrexed or docetaxel as second-line treatment in patients with advanced non-small-cell lung cancer: a meta-analysis of 14 randomized controlled trials

【24h】

Efficacy of combining targeted therapy with pemetrexed or docetaxel as second-line treatment in patients with advanced non-small-cell lung cancer: a meta-analysis of 14 randomized controlled trials

机译：靶向治疗联合培美曲塞或多西紫杉醇作为晚期非小细胞肺癌患者二线治疗的疗效：一项14项随机对照试验的荟萃分析

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

Objectives:

机译：目标：

著录项

来源
《Current medical research and opinion》 |2014年第11期|共10页
作者
Li Xuyuan; Wang Hongbiao; Lin Wenzhao; Xu Qini;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类医药、卫生;
关键词
Advanced non-small-cell lung cancer; Chemotherapy; Efficacy; Meta-analysis; Targeted therapy; toxicity;

机译：晚期非小细胞肺癌;化学疗法;疗效;Meta分析;靶向治疗;毒性;

相似文献

外文文献
中文文献
专利

1. Efficacy of combining targeted therapy with pemetrexed or docetaxel as second-line treatment in patients with advanced non-small-cell lung cancer: a meta-analysis of 14 randomized controlled trials [J] . Li Xuyuan, Wang Hongbiao, Lin Wenzhao, Current medical research and opinion . 2014,第11期

机译：靶向治疗联合培美曲塞或多西紫杉醇作为晚期非小细胞肺癌患者二线治疗的疗效：一项14项随机对照试验的荟萃分析
2. Efficacy of epidermal growth factor receptor inhibitors versus chemotherapy as second-line treatment in advanced non-small-cell lung cancer with wild-type EGFR: A meta-analysis of randomized controlled clinical trials [J] . ZhaoN., ZhangX.-C., YanH.-H., Lung cancer: Journal of the International Association for the Study of Lung Cancer . 2014,第1期

机译：表皮生长因子受体抑制剂与化学疗法作为野生型EGFR晚期非小细胞肺癌二线治疗的疗效：一项随机对照临床试验的荟萃分析
3. Weekly docetaxel vs. docetaxel-based combination chemotherapy as second-line treatment of advanced non-small-cell lung cancer patients The DISTAL-2 randomized trial. [J] . Gebbia V, Gridelli C, Verusio C, Lung cancer: Journal of the International Association for the Study of Lung Cancer . 2009,第2期

机译：每周以多西他赛与多西他赛为基础的联合化疗作为晚期非小细胞肺癌患者的二线治疗DISTAL-2随机试验。
4. Pemetrexed versus docetaxel single agent chemotherapy in chemotherapy-naive elderly patients with advanced non-small cell lung cancer [C] . Hua Xin, Zhenguo Han, Haibo Huang 2011 International Conference on Human Health and Biomedical Engineering . 2011

机译：培美曲塞与多西他赛单药化疗在未接受化疗的老年晚期非小细胞肺癌患者中的作用
5. Predictive Biomarkers of the Efficacy of Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Treating Advanced Non-small Cell Lung Cancer: A Systematic Review of Randomized Controlled Trials [D] . Yang, Zuyao. 2014

机译：表皮生长因子受体酪氨酸激酶抑制剂治疗晚期非小细胞肺癌疗效的预测生物标志物：随机对照试验的系统评价。
6. SELECT-2: a phase II double-blind randomized placebo-controlled study to assess the efficacy of selumetinib plus docetaxel as a second-line treatment of patients with advanced or metastatic non-small-cell lung cancer [O] . J -C Soria, A Fülöp, C Maciel, -1

机译：SELECT-2：一项II期双盲随机安慰剂对照研究旨在评估selumetinib和docetaxel作为晚期或转移性非小细胞肺癌患者的二线治疗的疗效
7. The impact of induction chemotherapy on the outcome of second-line therapy with pemetrexed or docetaxel in patients with advanced non-small-cell lung cancer [O] . Weiss, GJ, Rosell, R., Fossella, F., 2017

机译：晚期非小细胞肺癌患者诱导化疗对培美曲塞或多西他赛二线治疗结果的影响

Efficacy of combining targeted therapy with pemetrexed or docetaxel as second-line treatment in patients with advanced non-small-cell lung cancer: a meta-analysis of 14 randomized controlled trials

摘要

著录项

相似文献

相关主题

期刊订阅